Leonard M. Greenstein Tarsus Pharmaceuticals, Inc. (TARS) insider trading activity

Leonard M. Greenstein is Chief Financial Officer of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 26,785 shares of TARS, which is worth approximately $864,351. The most recent transaction as insider was on Apr 20, 2023, when has been sold 5,000 shares (Common Stock) at a price of $14.02 per share, resulting in proceeds of $70,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.8K

0% 3M change

0% 12M change

Total Value Held $864,351

Leonard M. Greenstein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 20 2023	SELL Open market or private sale	$70,100 $14.02 p/Share	5,000 Reduced 15.73%	26,785 Common Stock
Mar 23 2023	SELL Open market or private sale	$4,203 $12.15 p/Share	346 Reduced 1.08%	31,785 Common Stock
Mar 22 2023	SELL Open market or private sale	$4,196 $12.64 p/Share	332 Reduced 1.02%	32,131 Common Stock
Mar 21 2023	SELL Open market or private sale	$4,202 $12.89 p/Share	326 Reduced 0.99%	32,463 Common Stock
Mar 20 2023	SELL Open market or private sale	$4,199 $12.61 p/Share	333 Reduced 1.01%	32,789 Common Stock
Mar 17 2023	SELL Open market or private sale	$4,196 $13.28 p/Share	316 Reduced 0.95%	33,122 Common Stock
Mar 16 2023	SELL Open market or private sale	$71,406 $13.44 p/Share	5,313 Reduced 13.71%	33,438 Common Stock
Mar 15 2023	BUY Exercise of conversion of derivative security	-	4,462 Added 10.33%	38,751 Common Stock
Feb 16 2023	SELL Open market or private sale	$75,600 $15.12 p/Share	5,000 Reduced 12.73%	34,289 Common Stock
Jan 19 2023	SELL Open market or private sale	$72,800 $14.56 p/Share	5,000 Reduced 11.29%	39,289 Common Stock
Dec 15 2022	SELL Open market or private sale	$73,200 $14.64 p/Share	5,000 Reduced 10.14%	44,289 Common Stock
Nov 17 2022	SELL Open market or private sale	$82,700 $16.54 p/Share	5,000 Reduced 9.21%	49,289 Common Stock
Oct 20 2022	SELL Open market or private sale	$81,300 $16.26 p/Share	5,000 Reduced 8.43%	54,289 Common Stock
Sep 15 2022	SELL Open market or private sale	$80,150 $16.03 p/Share	5,000 Reduced 7.78%	59,289 Common Stock
Aug 18 2022	SELL Open market or private sale	$81,500 $16.3 p/Share	5,000 Reduced 7.22%	64,289 Common Stock

LMG

Leonard M. Greenstein

Chief Financial Officer

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARS shares.

Notify only if

Value

Insider Trading

Get notified when an Tarsus Pharmaceuticals, Inc. insider buys or sells TARS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Tarsus Pharmaceuticals, Inc.

Track Activities on TARS

Account